Rivera, Josephine D.

HRN: 22-72-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
CEFTRIAXONE 1G (VIAL)
03/02/2023
03/09/2023
IV
2gms
OD
UTI
Waiting Final Action 
06/03/2023
CEFTRIAXONE 1G (VIAL)
06/03/2023
06/10/2023
IV
2 Grams
OD
Septicemia; T/C UTI
Waiting Final Action 
06/05/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/05/2023
06/09/2023
ORAL
500mg
OD
CAP MR
Waiting Final Action 
06/03/2023
CLINDAMYCIN 300MG (CAP)
06/07/2023
06/13/2023
PO
600mg
QID
Infected Wound
Waiting Final Action 
06/03/2023
MUPIROCIN 2%, 15G (TUBE)
06/07/2023
06/13/2023
TOPICAL
1g
TID
Cellulitis
Waiting Final Action 
06/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/07/2023
06/14/2023
IV
600mg
Q6H
Cellulitis
Waiting Final Action 
06/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/07/2023
06/14/2023
IV
4.5grams
Q8H
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: